Observation of the therapeutic effect of handheld induction therapy combined with electromyographic biofeedback on post-stroke dysphagia.
Abstract
Objective
To evaluate the clinical efficacy of handheld induction therapy combined with electromyographic (EMG) biofeedback for post-stroke dysphagia in a real-world setting.
Methods
In this single-center retrospective cohort study, 105 patients with post-stroke dysphagia were enrolled; after multinomial propensity score (GPS) estimation with common support trimming, 96 patients (32 per group) were included in the final analysis: Group A (conventional treatment), Group B (conventional treatment + EMG biofeedback), and Group C (conventional treatment + EMG biofeedback + handheld induction therapy). The efficacy was assessed after 4 weeks by comparing videofluoroscopic swallowing study (VFSS) scores, Modified Mann Assessment of Swallowing Ability (MASA) scores, Functional Oral Intake Scale (FOIS) scores, and overall effective rates among the three groups.
Results
After treatment, Group C had significantly higher VFSS oral-phase, pharyngeal-phase, and aspiration scores than Groups A and B (all P < 0.001), as well as higher MASA scores (85.37 ± 6.54 vs. 73.25 ± 6.24 and 73.31 ± 6.31, respectively; all P < 0.001), and FOIS scores (6.05 ± 0.35 vs. 5.14 ± 0.28 and 5.09 ± 0.31, respectively; all P < 0.001). The total effective rate was highest in Group C (96.88%, 31/32), followed by Group B (84.38%, 27/32) and Group A (71.88%, 23/32), with a significant difference among the three groups (P = 0.025). Adverse reactions did not differ significantly (P = 0.440).
Conclusion
Handheld induction therapy combined with EMG biofeedback may effectively improve swallowing function and clinical efficacy in post-stroke dysphagia, with favorable safety; further prospective studies are warranted.